MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-11-2026
Organovo Holdings DSO Ratio 2011-2026 | ONVO
Annual DSO Ratio Organovo Holdings
| 2025 | 2024 | 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 79.8 | 310 | - | - | 18.4 | 65.9 | 81.5 | 55.8 | 63.7 | - | - | 166 | 49.4 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 310 | 18.4 | 98.9 |
Quarterly DSO Ratio Organovo Holdings
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114 | 104 | 76.5 | - | 105 | 117 | 94.8 | - | 803 | - | 183 | - | 26.5 | - | - | - | - | - | - | - | - | - | - | - | 120 | 177 | 38.6 | 71.7 | 59.9 | 64.6 | 73.1 | 84.9 | 121 | 87 | 68.6 | 94.2 | 107 | 13.5 | 9.73 | 21.7 | 53.7 | 20.7 | 15.2 | - | 9.85 | 29.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 803 | 9.73 | 98.8 |
DSO Ratio of other stocks in the Diagnostics research industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Accelerate Diagnostics
AXDX
|
291 | - | -61.36 % | $ 2.46 M |  USA |
 |
Agilent Technologies
A
|
63.8 | $ 118.37 | -1.17 % | $ 36 B | USA |
 |
Burning Rock Biotech Limited
BNR
|
31.7 | $ 19.58 | -4.79 % | $ 211 M |  China |
 |
Aspira Women's Health
AWH
|
1.17 K | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | USA |
 |
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | USA |
 |
Medpace Holdings
MEDP
|
50.4 | $ 520.39 | 0.36 % | $ 15 B | USA |
 |
CareDx, Inc
CDNA
|
51.5 | $ 21.48 | 22.25 % | $ 1.14 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M |  Britain |
 |
NeoGenomics
NEO
|
77.7 | $ 8.39 | -3.34 % | $ 1.07 B | USA |
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Exact Sciences Corporation
EXAS
|
30.8 | - | - | $ 19.8 B | USA |
 |
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
94.7 | $ 1.41 | -0.69 % | $ 1.88 M | USA |
 |
Castle Biosciences
CSTL
|
49.2 | $ 24.39 | -0.93 % | $ 677 M | USA |
 |
Senseonics Holdings
SENS
|
10.3 | $ 6.77 | -1.88 % | $ 282 M | USA |
 |
Soleno Therapeutics
SLNO
|
27 | $ 52.62 | 0.09 % | $ 2.67 B | USA |
 |
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | China |
 |
Neuronetics
STIM
|
48.7 | $ 1.35 | -2.87 % | $ 89 M | USA |
 |
Charles River Laboratories International
CRL
|
65 | $ 181.2 | 0.35 % | $ 8.98 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | USA |
 |
Thermo Fisher Scientific
TMO
|
70 | $ 524.15 | -1.41 % | $ 198 B | USA |
 |
Danaher Corporation
DHR
|
55.3 | $ 194.8 | -1.69 % | $ 139 B | USA |
 |
Interpace Biosciences
IDXG
|
66.9 | $ 1.95 | -11.36 % | $ 8.63 M | USA |
 |
Trinity Biotech plc
TRIB
|
87.2 | $ 0.7 | -0.83 % | $ 61.9 M |  Irlanda |
 |
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | USA |
 |
Twist Bioscience Corporation
TWST
|
44.5 | $ 56.37 | -2.17 % | $ 3.37 B | USA |
 |
Illumina
ILMN
|
61.3 | $ 130.3 | -1.48 % | $ 20.7 B | USA |
 |
Fulgent Genetics
FLGT
|
77.4 | $ 15.95 | -1.36 % | $ 482 M | USA |
 |
Guardant Health
GH
|
46.1 | $ 84.69 | -0.21 % | $ 10.6 B | USA |
 |
QIAGEN N.V.
QGEN
|
30.8 | - | - | $ 10.6 B |  Niderland |
 |
Anixa Biosciences
ANIX
|
275 | $ 2.82 | -3.75 % | $ 91.5 K | USA |
 |
Biomerica
BMRA
|
57.7 | $ 2.19 | 3.79 % | $ 5.03 M | USA |
 |
Waters Corporation
WAT
|
306 | $ 321.93 | -1.31 % | $ 19.2 B | USA |
 |
ICON Public Limited Company
ICLR
|
68.5 | $ 116.76 | 0.22 % | $ 9.63 B | Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
52.9 | $ 268.36 | 0.61 % | $ 22.3 B | USA |
 |
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K |  Israel |
 |
Myriad Genetics
MYGN
|
52.3 | $ 5.16 | -0.67 % | $ 478 M | USA |
 |
Lantheus Holdings
LNTH
|
80.5 | $ 83.68 | -0.31 % | $ 5.65 B | USA |
 |
Neogen Corporation
NEOG
|
66.6 | $ 9.26 | -1.7 % | $ 2.01 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
44.9 | $ 193.65 | 1.16 % | $ 21.5 B | USA |